Role of [18F]fluoro-2-deoxy-D-glucose positron emission tomography in re-recurrent cervical cancer

International Journal of Gynecological Cancer

Volumn 16, Issue 6, 2006, Pages 1994-2003

  Lin, C T ^a   Yen, T C ^a   Chang, T C ^a   Ng, K K ^a   Tsai, C S ^a   Ho, K C ^a   Lai, C H ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

FDG PET; Prognosis; Recurrent cervical cancer; Resalvage

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL DECISION MAKING; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECURRENT CANCER; SALVAGE THERAPY; SCORING SYSTEM; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; UTERINE CERVIX CANCER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; GENERAL APPARATUS, EQUIPMENT AND SUPPLIES; METHODOLOGY; MIDDLE AGED; PROGNOSIS; RECURRENT DISEASE; RISK FACTOR; UTERINE CERVIX TUMOR;

ADULT; AGED; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; PROGNOSIS; RECURRENCE; RISK FACTORS; SURVIVAL RATE; TOMOGRAPHY SCANNERS, X-RAY COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 33845514126     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00729.x     Document Type: Article

References (23)

1. Parkin DM, Bray F, Ferlay J et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 2001;94:153-6.
2. NIH Consensus Development Panel. National Institutes of Health consensus development conference statement on cervical cancer. Gynecol Oncol 1997;66:351-61.
3. Lai CH. Management of recurrent cervical cancer. Chang Gung Med J 2004;72:711-9.
4. Waggoner SE. Cervical cancer. Lancet 2003;361:2217-25.
5. Hong JH, Tsai CS, Lai CH et al. Recurrent squamous cell carcinoma of cervix following definitive radiotherapy. Int J Radiat Oncol Biol Phys 2004;60:249-57.
6. Sasaoka M, Fuwa N, Asano A, Matsumoto A, Katou E, Ito Y. Patterns of failure in carcinoma of the uterine cervix treated with definitive radiotherapy alone. Am J Clin Oncol 2001;24:586-90.
7. Kasamatsu T, Onda T, Yamada T, Tsunematsu R. Clinical aspects and prognosis of pelvic recurrence of cervical carcinoma. Int J Gynaecol Obstet 2005;89:39-44.
8. Yen TC, Ng KK, Ma SY et al. Value of dual-phase 2-fluoro-2-deoxy-D- glucose positron emission tomography in cervical cancer. J Clin Oncol 2003;21:3651-8.
9. Pandit-Taskar N. Oncologic imaging in gynecologic malignancies. J Nucl Med 2005;46:1842-50.
10. Yen TC, Lai CH. Positron emission tomography in gynecologic cancer. Semin Nucl Med 2006;36:93-104.
11. 18F]fluoro-2-deoxy-D-glucose positron emission tomography. Cancer 2004;100:544-52.
12. Chang TC, Law KS, Hong JH et al. Positron emission tomography for unexplained serum scc-ag elevation in cervical cancer patients - a phase II study. Cancer 2004;101:164-71.
13. Sakurai H, Suzuki Y, Nonaka T et al. FDG-PET in the detection of recurrence of uterine cervical carcinoma following radiation therapytumor volume and FDG uptake value. Gynecol Oncol. 2006;100:601-7.
14. Unger JB, Ivy JJ, Connor P et al. Detection of recurrent cervical cancer by whole-body FDG PET scan in asymptomatic and symptomatic women. Gynecol Oncol 2004;94:214-6.
15. Chao A, Lai CH, Lin CT et al. Intralesional injection for hepatic metastasis from cervical carcinoma: a report of two cases. J Reprod Med 2001;46:1008-12.
16. Chou HH, Wang CC, Lai CH et al. Isolated paraaortic lymph node recurrence after definitive irradiation for cervical carcinoma. Int J Radiat Oncol Biol Phys 2001;51:442-8.
17. Singh AK, Grigspy PW, Rader JS, Mutch DF, Powell MA. Cervix carcinoma, concurrent chemoradiotherapy, and salvage of isolated paraaortic lymph node recurrence. Int J Radiat Oncol Biol Phys 2005;61:450-5.
18. Seki M, Nakagawa K, Tsuchiya S et al. Surgical treatment of pulmonary metastases from uterine cervical cancer. J Thorac Cardiovasc Surg 1992;104:876-81.
19. Anderson TM, McMahon JJ, Nwogu CE et al. Pulmonary resection in metastatic uterine and cervical malignancies. Gynecol Oncol 2001;83:472-6.
20. Kaseki H, Yasui K, Niwa K, Mizuno K, Inoue T, Ota M. Hepatic resection for metastatic squamous cell carcinoma from the uterine cervix. Gynecol Oncol 1992;44:284-7.
21. Bipat S, Glas AS, van der Velden J et al. Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review. Gynecol Oncol 2003;91:59-66.
22. Anzai Y, Carroll WR, Quint DJ et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro- D-glucose PET and MR imaging diagnoses. Radiology 1996;200:135-41.
23. Yen TC, See LC, Chang TC et al. Defining the priority of using 18F-FDG PET for recurrent cervical cancer. J Nucl Med 2004;45:1632-9.